Latest from Tuberous Sclerosis Alliance

The Tuberous Sclerosis Alliance (TS Alliance) have prepared an FAQ to address concerns from the tuberous sclerosis complex (TSC) community regarding the COVID-19 outbreak. 
The previously approved therapy is now indicated for treatment in pediatric patients age 2 to 10.
The announcement formally connects Bcureful and the Tuberous Sclerosis Alliance together after working closely together for over the past 8 years. 
The Tuberous Sclerosis Alliance has announced updates to access of everolimus, a drug used to treat several conditions associated with tuberous sclerosis complex. 
SAP Partner Banner